Tanya Hay - Concepedia

Author

Tanya Hay

Also Known As

Tanya Hay, Tanya L Hay, Tanya L. Hay

Publications

289

Citations

H-Index

Concepts

All Affiliations

Tanya Hay is an author at Pfizer (United Kingdom) specializing in pharmacotherapy, pharmacokinetics, and electrophysiology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	36
2	Pharmacology	1	1	36
3	Drug Discovery	1	1	36
4	Ion Channels	1	1	36
5	Pharmacokinetics	1	1	36

Tanya Hay

Publications

247

Citations

H-Index

Page 1

	Year	Citations
Application of PBPK modelling in drug discovery and development at Pfizer Hannah M. Jones, Maurice Dickins, Kuresh Youdim, Xenobiotica	2011	93
Modulation of the Partition Coefficient between Octanol and Buffer at pH 7.4 and p Ka to Achieve the Optimum Balance of Blood Clearance and Volume of Distribution for a Series of Tetrahydropyran Histamine Type 3 Receptor Antagonists Tanya Hay, Rhys D.O. Jones, Kevin Beaumont, Drug Metabolism and Disposition	2009	46
Discovery and Optimization of Selective Na <sub>v</sub> 1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain Sharan K. Bagal, Peter J. Bungay, Stephen M. Denton, ACS Medicinal Chemistry Letters	2015	40
Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels Hannah M. Jones, Richard P. Butt, Rob Webster, Clinical Pharmacokinetics Four Selective InhibitorsHuman PharmacokineticsPhysiologyPharmacologyIon Channels	2016	36
Application of a high‐resolution in vitro human MDR1‐MDCK assay and in vivo studies in preclinical species to improve prediction of CNS drug penetration Licong Jiang, Sanjeev Kumar, Marc Nuechterlein, Pharmacology Research & Perspectives	2022	19
Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms Anthony Harrison, Iain Gardner, Tanya Hay, Xenobiotica	2011	13

Page 1